Cardinal Health stock holds its ground after fiscal 2025 gains
Published on 07/20/2026 at 03:45 | Editorial responsibility: Rafael Müller, Editor-in-Chief AD HOC NEWS
Cardinal Health (US14149Y1082) is anchored by fiscal 2025 numbers that matter to shareholders: revenue reached $222.6 billion, adjusted operating earnings were $2.4 billion, and adjusted diluted EPS came in at $8.03 for the year ended 30 June 2025. The company’s latest annual filing shows how scale, margin mix, and pharmacy distribution still drive the stock story.
Revenue tops $222.6 billion
For the year ended 30 June 2025, Cardinal Health reported revenue of $222.6 billion, up from $226.8 billion in fiscal 2024 on a comparable basis described in its annual report context. Adjusted operating earnings of $2.4 billion and adjusted diluted EPS of $8.03 show that the business kept generating large absolute profit even as the revenue base shifted.
EPS at $8.03
The company also reported adjusted free cash flow of $1.6 billion in fiscal 2025, after $1.9 billion in fiscal 2024, which gives a second lens on capital efficiency. Net earnings attributable to Cardinal Health were $1.8 billion for fiscal 2025, against $1.4 billion in fiscal 2024, a comparison that underlines how the earnings line moved faster than cash generation over the same period.
The numbers point to a stock where scale is still the core defense. Revenue above $222 billion, EPS at $8.03, and free cash flow at $1.6 billion are all large enough to keep the market focused on execution rather than narrative.
Pharmacy and distribution
Pharmaceutical and specialty distribution remains the central product engine for Cardinal Health, with large-scale pharmacy and manufacturer relationships supporting the annual revenue base. In fiscal 2025, that mix mattered more than any single product launch because the company’s value proposition is built on throughput, contracts, and logistics density.
Stock level and venue
Cardinal Health stock is listed on the NYSE and trades in USD. For a current market read, the most useful reference point is the company’s annual-results base: fiscal 2025 revenue of $222.6 billion, adjusted operating earnings of $2.4 billion, and adjusted diluted EPS of $8.03, all tied to the year ended 30 June 2025.
Fiscal 2025 results and company filing
Key annual figures for revenue, EPS, operating earnings, cash flow, and net income are tied to the latest filed fiscal year.
Cardinal Health profile
Cardinal Health stock facts
- Company: Cardinal Health, Inc.
- ISIN: US14149Y1082
- Ticker: NYSE: CAH
- Trading venue: NYSE
- Sector / Industry: Health Care / Healthcare Distributors
- Index membership: S&P 500
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
